Clinical Trials

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT06305598 2026-05-15

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1 Recruiting

14 enrolled

Prostatic Neoplasms

NCT07476001 2026-05-15

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

12 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT04363164 2026-04-06

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

150 enrolled

Castration Resistant Metastatic Prostate Cancer

NCT07142551 2026-03-11

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

60 enrolled

Phase 4 Not yet recruiting

Prostatic Neoplasms

NCT07278362 2026-02-23

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

35 enrolled

Phase 2 Active not recruiting

Eunuchism, Prostatic Neoplasms

NCT04558866 2026-02-12

ExBAT

51 enrolled

Prostatic Neoplasms

NCT06039371 2026-01-14

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

69 enrolled

Prostatic Neoplasms

NCT06059118 2026-01-14

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT06100705 2025-11-04

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

26 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT03516812 2025-09-29

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

36 enrolled 14 charts

Castration-Resistant Prostate Carcinoma

NCT03716739 2025-09-23

Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

136 enrolled

Prostatic Neoplasms

NCT06922318 2025-09-17

The COSMYC Trial (COmbined Suppression of MYC)

50 enrolled

Prostatic Neoplasms

NCT03554317 2024-02-20

COMBAT-CRPC

45 enrolled 18 charts

Prostatic Neoplasms

NCT02995330 2024-02-13

Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Terminated

3 enrolled 8 charts

Prostatic Neoplasms

NCT04424654 2022-08-03

PSMA-BAT

20 enrolled

Prostatic Neoplasms

NCT02090114 2022-06-27

Restore

112 enrolled 20 charts

Prostatic Neoplasms

NCT02286921 2020-11-06

Transformer

222 enrolled 25 charts

Castration Resistant Metastatic Prostate Cancer

NCT01750398 2016-12-05

BAT

33 enrolled 16 charts

Prostatic Neoplasms

NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

Phase 3 Completed

53 enrolled 8 charts

Fatigue, Neoplasms

NCT01084759 2016-05-09

A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer

Phase NA Completed

16 enrolled 12 charts